The regulation of similar bio-therapeutic products varies widely among the different Latin American countries. While some of them are yet to introduce their own regulation, others — like Brazil and Mexico — have opened ways to cheaper, complex and safe biological treatment for patients. However, many things need improving and a lot of experience is still necessary to develop a mature LATAM Biosimilars Market. Biosimilars Forum 2018 is a unique and effective meeting point to share the information and experience Latin America’s Pharmaceutical Industry needs to develop a dynamic and thriving biosimilars market. Join us in Mexico and trigger a quantum leap in Latin American Healthcare!

PTC Therapeutics, Argentina

Sr. Regional Commercial & Market Access Manager

Broad experience and knowledge in pharmaceutical business. This includes sales, government affairs, commercial strategies, market access, launched a large variety of products from the marketing area, building field sales team force focused on specialized medicines such as: specialized medicines, monoclonal antibodies, small molecules, biosimilars and gene therapies.